Please use this identifier to cite or link to this item:
|Title:||Expression of urocortin 2 and its inhibitory effects on intracellular Ca2+ via L-type voltage-gated calcium channels in rat pheochromocytoma (PC12) cells||Authors:||Tao, J.
|Keywords:||Intracellular Ca2+ concentration ([Ca2+] i)
Voltage-gated calcium channel (VGCC)
Whole-cell patch clamp
|Issue Date:||4-Dec-2006||Citation:||Tao, J., Zhang, Y., Soong, T.W., Li, S. (2006-12-04). Expression of urocortin 2 and its inhibitory effects on intracellular Ca2+ via L-type voltage-gated calcium channels in rat pheochromocytoma (PC12) cells. Neuropsychopharmacology 31 (12) : 2600-2609. ScholarBank@NUS Repository.||Abstract:||Urocortin 2, a new member of the corticotrophin-releasing factor (CRF) neuropeptide family, was reported to be widely expressed in the central nervous system and peripheral tissues. Here, we detected urocortin 2 mRNA in PC12 cells using reverse transcription-polymerase chain reaction (RT-PCR). Furthermore, we observed its effects on intracellular Ca2+ concentration ([Ca 2+]i) using confocal microscopy and flow cytometry and on voltage-gated calcium channel (VGCC) currents using whole-cell patch clamp. Our results showed that urocortin 2 mRNA was coexpressed with CRF, and CRF receptor (CRFR) 2β in undifferentiated PC12 cells, but not CRFR1 or CRFR2α. KCl (40 mM) or Bay K8644 (1 μM), an L-type VGCC activator, increased [Ca 2+]i. Pretreatment of the cells with urocortin 2 significantly diminished the effect of Bay K8644 or KCl. Urocortin 2 showed no influence on [Ca2+]i in tyrode's solution containing EGTA or Ca2+-free tyrode's solution. It reversibly inhibited the VGCC currents in a concentration-dependent manner, but had no apparent effects on the cells treated with nifedipine (1 μM), an L-type VGCC blocker. Urocortin 2 up-shifted the current-voltage curves. No frequency-dependence of urocortin 2 effects on IBa was observed. The inhibitory effects of urocortin 2 on VGCC currents or [Ca2+]i were not affected by astressin 2B, an antagonist of CRFR2. As calcium overload play a key role in some neuronal degenerative diseases such as Alzheimer's and Parkinson's diseases, our results suggest that urocortin 2 may be a potentially interesting agent for the treatment of these diseases. © 2006 Nature Publishing Group All rights reserved.||Source Title:||Neuropsychopharmacology||URI:||http://scholarbank.nus.edu.sg/handle/10635/109338||ISSN:||0893133X|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 28, 2018
WEB OF SCIENCETM
checked on Dec 31, 2018
checked on Jan 26, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.